KeyBanc lowered the firm’s price target on Alcon (ALC) to $91 from $98 to reflect challenging second half of 2025 setup, while keeping an Overweight rating on the shares. The firm continues to view Alcon as a key long-term idea but believes there may be limited upside to its second half of 2025 guidance.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALC:
- Staar Surgical shareholder issues letter opposing Alcon acquisition
- Staar Surgical sale faces growing opposition from Broadwood
- Activist Jana Partners Takes Stake in Cooper Companies, Presses for Strategic Review
- Broadwood urges shareholders vote ‘AGAINST’ acquisition of STAAR by Alcon
- Broadwood: Proxy advisory firms recommend Staar shareholders vote against sale